Variations in DNA methylation levels in the placenta are thought to influence gene expression and are associated with complications of pregnancy, like fetal growth restriction (FGR). The most important cause for FGR is placental dysfunction. Here, we examined whether changes in DNA methylation, followed by gene expression changes, are mechanistically involved in the etiology of FGR. In this retrospective casecontrol study, we examined the association between small-forgestational-age (SGA) children and both DNA methylation and gene expression levels of the genes WNT2, IGF2/H19, SERPI-NA3, HERVWE1, and PPARG in first-trimester placental tissue. We also examined the repetitive element LINE-1. These candidate genes have been reported in the literature to be associated with SGA. We used first-trimester placental tissue from chorionic villus biopsies. A total of 35 SGA children (with a birth weight below the 10th percentile) were matched to 70 controls based on their gestational age. DNA methylation levels were analyzed by pyrosequencing and mRNA levels were analyzed by real-time PCR. None of the average DNA methylation levels, measured for each gene, showed a significant difference between SGA placental tissue compared to control tissue. However, hypermethylation of WNT2 was detected on two CpG positions in SGA. This was not associated with changes in gene expression. Apart from two CpG positions of the WNT2 gene, in early placenta samples, no evident changes in DNA methylation or expression were found. This indicates that the already reported changes in term placenta are not present in the early placenta, and therefore must arise after the first trimester.
INTRODUCTION
Environmental factors are thought to influence the epigenome of the placenta and the fetus [1] . DNA methylation is one of these epigenetic changes [2] . Compared with somatic tissues, the human placenta has a low global DNA methylation, which might allow a high expression of many genes. It is hypothesized that changes in DNA methylation in the placenta can lead to placenta dysfunction, resulting in pregnancy complications, such as fetal growth restriction (FGR) [3] . Small for gestational age (SGA) is often taken as a proxy for FGR, and is defined as a birth weight below the 10th percentile of a birth weight curve [4, 5] . Causes of FGR are divided into fetal, maternal, and placental categories. However, placental dysfunction accounts for the majority of FGR cases [6] . FGR is an important cause of perinatal morbidity and mortality. Apart from these direct adverse outcomes, low birth weight of the fetus is also associated with health problems, such as hypertension, coronary heart disease and diabetes [7] , later in life.
In humans, about 50% of the DNA consists of repetitive elements, such as LINE-1, DNA that does not code for proteins. Lower DNA methylation of LINE-1 has been found in placentas of neonates with a lower birth weight [8] . Several mouse studies show the important role of Wnt2 in placental vascularization. Mice deficient in Wnt2 show a reduction in birth weight, and fetal survival is only 50%, because of improper placental function [9] . Ferreira et al. examined WNT2 methylation in the postdelivery placenta and found high WNT2 promoter DNA methylation and reduced WNT2 expression in association with low birth weight [10] . The imprinted IGF2/ H19 gene complex is associated with fetal and placental growth, affecting birth weight [11, 12] . It is also known that altered DNA methylation patterns on chromosome 11p15 (location of IGF2/H19) are related to growth disorders, such as Beckwith-Wiedeman and Silver-Russel syndrome [13, 14] . Koukoura et al. showed lower DNA methylation level and higher expression of H19 associated with FGR [15] . Several other studies have shown significantly lower IGF2 gene expression in term FGR samples [16, 17] . However, Tabano et al. did not find any differences in DNA methylation status of the IGF2/H19 gene between FGR and controls [18] . SERPI-NA3 belongs to the family of serine protease inhibitors, which are glycoproteins. When compared to normal placentas, SGA and pre-eclamptic placentas exhibit lower DNA methylation levels. An overexpression of SERPINA3 in pre-eclampsia and SGA was found [19, 20] . HERVWE1 belongs to the endogenous retroviruses, and is highly expressed in the placenta, suggesting an important role. The protein product of HERVWE1 is syncytin-1, and this protein is involved in fusion of cytotrophoblast cells to form the syncytial layer of the placenta [21, 22] . It has been shown that the structure of the syncytium in the placenta is significantly different in FGR pregnancies [23] . Ruebner et al. found that hypermethylation of the HERVWE1 promoter region is associated with reduced syncytin-1 expression levels in abnormal term placentas, including FGR [24] . PPARG is a transcription factor that is highly expressed in placenta trophoblast cells. This gene is important, as it regulates the transport of fatty acids from the placenta to the fetus [25, 26] . Pparg null mice are lethal, due to abnormal placental development with a characteristic reduction of lipid droplets in trophoblasts [27] . In human term placenta, PPARG expression is reduced in SGA children, presumably due to higher DNA methylation status [28] . As just described, altered DNA methylation patterns of selected genes have been demonstrated in growth-restricted placentas at term. However, it is not known whether these altered DNA methylation profiles are primarily causative for, or the result of, FGR.
The aim of this study was to investigate the association of SGA and DNA methylation and expression patterns of selected genes in early placental tissue. Therefore, we used firsttrimester placenta obtained via chorionic villus biopsies (CVBs) from pregnancies that resulted in the birth of a SGA neonate.
MATERIALS AND METHODS

Patients
In the period of 2004-2009, villi of 695 CVBs were stored prospectively at the department of Obstetrics and Gynecology of the University Medical Center Groningen. The CVB was performed between 11 and 13 wk of gestation, mainly for maternal age (women over the age of 36 yr in the 18th wk of pregnancy) or serum screening-related risk of aneuploidy. Gestational age was confirmed by ultrasound (crown-rump length). Tissue was obtained vaginally by use of a biopsy catheter (K-CMA-5000; Cook). Surplus material, not needed for karyotyping, was obtained and decidua was mechanically separated from the villi. Follow-up of these pregnancies was performed by use of a questionnaire returned by the patient postpartum. The pregnancies with known follow-up were analyzed and the clinical data were extracted from the patient files [29] [30] [31] . SGA was defined as a birth weight below the 10th percentile. The birth weight percentile was calculated with Dutch birth weight tables, which correct for gestational age, parity, and gender [32] . We included only singleton pregnancies. We selected 35 neonates with a birth weight below the 10th percentile. For each case, two controls were selected with a birth weight between the 20th and 80th percentiles, matched for gestational age at the time of sampling. Exclusion criteria for the controls were pre-existent maternal disorders, concurrent morbidity, smoking, use of medication that might influence intrauterine growth, pregnancy complications (such as pre-eclampsia), and multiple pregnancy. Fetal karyotyping showed no chromosomal abnormalities. Cases with prenatal complications of hypertension and preeclampsia and smoking were not excluded, as these factors are known to be associated with FGR [33] . Patients were informed in writing that surplus material from chorionic villus sampling, not needed for diagnostics and otherwise discarded, could be used for research, and written informed consent was obtained. Samples were coded and outcomes anonymized. This is in accord with the ''Code for proper use of surplus human tissue,'' version 2002, of the National Dutch Federation of Medical Scientific Societies, and received approval from our local ethics review committee.
Gene Selection
To select relevant genes, we performed a systematic search using the following terms in PubMed: (DNA) methylation, epigenetics, gene, expression, intrauterine growth restriction, intrauterine growth retardation, fetal growth retardation, FGR, small for gestational age, and fetal growth. From this list, we selected potential biologically relevant genes. We also included a repetitive element to allow us to look at genome-wide DNA methylation changes. We decided to select a maximum of five genes in advance, and the generated list contains more relevant genes (Table 1) . Our search resulted in the repetitive element LINE-1 and the following five candidate genes: WNT2, IGF2/H19, SERPINA3, HERVWE1, and PPARG [10, 15, 19, 24, 28] . The genes were checked for a known promoter, using a promoter database (available at http:// rulai.cshl.edu/cgi-bin/TRED/tred.cgi?process¼home).
DNA Isolation and Bisulfite Treatment
Samples were prepared in GT buffer and stored at À208C or À808C. DNA was isolated using the DNeasy Blood&Tissue Kit (Qiagen, Hilden, Germany), according to the manufacturer's protocol. The tissue was homogenized by passing it through a syringe with a 20 G needle a minimum 5-10 times. The DNA was diluted in 100 ll buffer AE (Qiagen). To check quality and to exclude contamination, the DNA product was analyzed by gel electrophoresis. DNA concentrations and protein contamination of the samples were checked using a Nanodrop spectrophotometer (Isogen). Samples with a 260/230 ratio lower than 1.8 were cleaned using standard ethanol precipitation. Depending on the amount of DNA, the samples were resuspended in 20-100 ll buffer AE. After isolation, the samples were stored at 48C until bisulfite treatment.
Bisulfite treatment was performed using the EZ DNA Methylation-Gold Kit (Zymo Research), according to the supplier's protocol. Depending on the amount of DNA available, 200-500 ng of DNA was used per sample. Universally unmethylated and universally methylated DNA standards were used in the reactions as controls. The following conditions were used to generate bisulfate modified DNA: 10 min at 988C, 2.5 h at 648C, and then cooling to 48C. At the end of the procedure, the samples were eluted in 50 ll M-Elution Buffer (provided by Zymo Research).
PCR and Pyrosequencing
Primers for the selected genes were designed with PyroMark Assay Design software 2.0 (Qiagen; Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod.org). The examined CpG positions and their position in relation to the transcription start site are presented in Figure 1 . For most of the genes, we looked at the promoter region of the gene. For IGF2/H19, we looked in the region with CTCF binding sites, and for SERPINA3 we chose to examine the same region as did Chelbi et al. in their report of a lower DNA methylation level in pre-eclampsia and growth restriction [19] . PCR was performed using the PyroMark PCR Kit (Qiagen). PCR conditions are shown in RPE65; SLC25A18; MEP1A; PDC; OMG; NCOA3; CSTA; MFAP1; DNAJB4; ALDH3B2; GYS2; GGPS1; OAT.
An array examined genome-wide DNA methylation patterns in 206 term placentas from FGR children.
The listed genes were differently methylated in FGR.
Cordeiro et al. [38] PHLDA2 Fetal and placental samples were examined from spontaneous abortions or fetal deaths with FGR between 14 and 24 wk; n ¼20.
Lower DNA methylation in IC2 (region controlling PHLDA2) in FGR children. No significant differences between fetal and placental tissue with regard to the DNA methylation in FGR.
Marsit et al. [39]
HSDB11B2 DNA methylation was examined in 186 term placentas (appropriate-, small-, and large-forgestational-age infants).
Greater extent of DNA methylation in SGA infants.
Mulligan et al. [40]
NR3C1
Umbilical cord blood samples from 25 newborns from mothers living in an ongoing war region.
Maternal prenatal stress is correlated with newborn birth weight. Low newborn birth weight is correlated with higher DNA methylation of NRC1.
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Supplemental Table S2 . Pyrosequencing was used to determine the DNA methylation status of single CpGs. Samples were analyzed by the PyroMark Q24 (Qiagen), according to manufacturer's protocol. In each run, an internal control for bisulfite treatment was incorporated. Thereby, both universally methylated and universally unmethylated DNA was used in the runs as unmethylated or methylated control (the methylated and unmethylated gDNA Control Kit [Life Technologies] was used). Data were analyzed using the PyroMark Q24 Analysis Software 2.0 (Qiagen). The level of DNA methylation is given as a percentage.
Quantitative Real-Time PCR
The mRNA level of WNT2, IGF2/H19, SERPINA3, HERVWE1, and PPARG were detected by quantitative real-time PCR (qPCR). LINE-1 does not code for genetic information, but served as a surrogate marker for genome-wide DNA methylation. Therefore, its expression was not analyzed. RNA was isolated and purified using NucleoSpin RNA/protein Kit, according to manufacturer's protocol (Macherey-Nagel, Düren, Germany). Some samples were cleaned using Qiagen RNeasyMinElute Cleanup Kit. A total of 250 ng RNA was used to synthesize cDNA. Complimentary DNA was prepared with M-MLV reverse transcriptase, RT buffer, dNTP mix, random nonamers, RNAse OUT, and DTT. The mixture was briefly centrifuged with the RNA, and incubated at 258C for 10 min, then at 378C for 50 min, and then heated at 708C for 15 min.
Taqman PCR was used to determine the transcriptional profile of the selected genes. For 18SrRNA, WNT2, IGF2/H19, SERPINA3, and HERVWE1, the assays were provided by Applied Biosystems (Supplemental Table S3 ). The primer and probe sequences for PPARG and ACTB have been published previously (www.labpediatricsrug.nl) and are presented in Supplemental Table  S3 . All samples were run in duplicates on the 7900HT Fast Real-Time PCR System (Life Technologies). SDS 2.4 Software from Applied Biosystems was used to analyze the runs. The normalized means of ACTB and 18SrRNA were used as endogenous reference. Both genes were stably expressed in cases and controls (data not shown). Limited available material dictated that we could not perform a complete panel of housekeeping genes. 
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Statistical Analysis
All statistical analyses were performed using SPSS Statistics 20.0. For normally distributed data, the independent samples t-test was used, and data are presented as means 6 SD. When the data were not normally distributed, nonparametric tests were used (Mann-Whitney U-test), and the data are presented as median and range. Pearson correlation was performed for the correlation between qPCR data and DNA methylation. Outcomes were considered significant with a probability value of less than 0.05.
RESULTS
A total of 35 SGA neonates and 70 neonates with a normal birth weight were analyzed. The groups were different for maternal hypertension and smoking. Maternal and neonatal characteristics are presented in Table 2 . Some tissue samples were not sufficient for determination of DNA methylation patterns of all the proposed genes. The total of analyzed samples for DNA methylation analysis are presented in Table  3 .
The repetitive element LINE-1 showed an average DNA methylation level close to 50% in both groups. When analyzing the three CpGs separately, no differences were found between cases and controls (Table 3 ). In the case of WNT2, the first and second analyzed CpG showed a significantly higher DNA methylation level in SGA samples compared to controls (P ¼ 0.04 and P ¼ 0.04, respectively; Table 3 ). However, no changes in gene expression were found. When we looked at the association between WNT2 DNA methylation and WNT2 expression, no statistically significant correlation was found (Fig. 2) . When analyzing the DNA methylation level of the genes IGF2/H19, SERPINA3, HERVWE1, and PPARG, no significant differences were found in either the separate CpG positions or the average DNA methylation level between cases and controls (Table 3 ). There were also no significant differences in mRNA expression of these four genes between SGA cases and controls (data not shown). Furthermore, no correlation between DNA methylation and expression was found ( Supplemental Fig. S1 ). We also analyzed smoking; however, no differences were found for any of the examined genes, nor for DNA methylation or gene expression.
Interestingly, for IGF2/H19, we noticed the presence of a previously unknown single-nucleotide polymorphism at CpG4 in roughly 50% of all samples. Consequently, we excluded CpG4 from all statistical analyses.
DISCUSSION
Changes in DNA methylation of several genes in term placenta have been linked to SGA and have been associated with changed expression of these genes [1] . Since studies showing whether this is a cause or a consequence of FGR are lacking, we looked for DNA methylation differences in firsttrimester SGA placentas.
At first we found that the overall DNA methylation in firsttrimester SGA samples is not changed. Because the first-and second-examined CpG positions of WNT2 showed a significantly higher DNA methylation level in SGA cases, we used the program TFSEARCH to identify putative transcription factor binding sites. Transcription factor binding sites are likely epigenetic transcriptional regulation sites, as modifications here may influence transcription factor binding [34, 35] . We found that ADR1, MZF1, and SP1 bind to binding sites on the firstanalyzed CpG position of WNT2. It is possible that the changes in DNA methylation in the first CpG have a biological relevance, due to these transcription factors. Therefore, we looked at the expression of WNT2. However, no difference in expression was found between SGA and controls. We also analyzed the average DNA methylation level of the first five CpG positions of the total 12 CpG positions of the WNT2 gene that we examined. This was done because these are the same LEEUWERKE ET AL.
positions that were included in the Ferreira study, and in this way we were able to compare our results with theirs. However, no statistically significant differences were found, which suggests that the WNT2 differences in term SGA placentas, as described by Ferreira et al., namely, high DNA methylation of WNT2 in SGA placenta, are not present in the early placenta (data not shown) [10] . The lack of correlation between DNA methylation and gene expression for all our examined genes can be explained, since the relation between DNA methylation and gene expression is complex and gene expression is also dependent on other factors (e.g., histone acetylation) [2, 36] . Furthermore, as active gene transcription requires (tissue-specific) cofactors, DNA methylation does not always correlate with actual, but putative, transcription.
In our selection of genes we did not find, except for two separate CpG positions of WNT2, DNA methylation differences. Our results suggest that the reported DNA methylation changes in term SGA placenta occur later during pregnancy, at least after the first trimester. This could mean that the DNA methylation differences described in term placentas are a consequence of the pathology of FGR instead of causative for FGR.
In order to make a definite statement about the DNA methylation throughout pregnancy, we would have to measure the DNA methylation in term placentas in the same cases as we used for the CVB. Unfortunately, this material was not available. The CVB was taken in the 11th-13th wk of pregnancy. Most of these women were only visiting the University Medical Center Groningen for prenatal testing via a CVB. If the outcome of the CVB was normal, most women went back to standard, regional care by their own hospital or midwife and delivered there. For this reason, the ultrasound measurements, such as fetal biometry and doppler velocimetry, and the other clinical data (e.g., blood pressure) are for the biggest part missing. Because there is selectivity in missing data, as most of the data from our own hospital were available, this would result in bias. Therefore, we are unable to compare our laboratory findings with these specific clinical data. 
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Further limitations of this study are that we only examined a few candidate genes based on our literature search. Array studies could be helpful to select strong candidate genes for further research. We also admit that there is substantial variability in DNA methylation in the placenta. Therefore, to be able to validate SGA-associated genes, the differences must be remarkable.
Our study showed hypermethylation of the WNT2 gene on two CpG positions in SGA cases. However, no DNA methylation or expression changes were observed for the other genes in early placental material, between the 11th and 13th wk, related to SGA. This indicates that the DNA methylation and/or expression differences reported in the literature arise after the first trimester, between the second trimester and the term period.
